Código QR (código de barras bidimensional)

Alzheimer's disease drug development pipeline: 2023

Abstract Introduction Drugs that prevent the onset, slow progression, or improve cognitive and behavioral symptoms of Alzheimer's disease (AD) are needed. Methods We searched ClinicalTrials.gov for all current Phase 1, 2 and 3 clinical trials for AD and mild cognitive impairment (MCI) attributed to...

Fuld beskrivelse

Na minha lista:
Principais autores: Jeffrey Cummings, Yadi Zhou, Garam Lee, Kate Zhong, Jorge Fonseca, Feixiong Cheng
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2023-04-01
Serier:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Fag:
Alzheimer's disease
amyloid
biomarkers
clinical trials
Common Alzheimer's Disease Research Ontology (CADRO)
drug development
Online adgang:https://doi.org/10.1002/trc2.12385
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker